Off-label use of sodium valproate for schizophrenia.
Saved in:
| Title: | Off-label use of sodium valproate for schizophrenia. |
|---|---|
| Authors: | Horowitz E; Israeli Center for Technology Assessment in Health Care, Gertner Institute, Haim Sheba Medical Center, Ramat Gan, Israel., Bergman LC; Public Health and Health Systems Management Program, Bar Ilan University, Ramat Gan, Israel., Ashkenazy C; Yehuda Abarbanel Mental Health Center, Bat Yam, Israel., Moscona-Hurvitz I; Teva Pharmaceutical Industries, Ltd., Petach Tikva, Israel., Grinvald-Fogel H; Public Health and Health Systems Management Program, Bar Ilan University, Ramat Gan, Israel., Magnezi R; Public Health and Health Systems Management Program, Bar Ilan University, Ramat Gan, Israel. |
| Source: | PloS one [PLoS One] 2014 Mar 24; Vol. 9 (3), pp. e92573. Date of Electronic Publication: 2014 Mar 24 (Print Publication: 2014). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0092573 |
